Narrative update of clinical trials with antihypertensive drugs in children and adolescents

To date, our knowledge on antihypertensive pharmacological treatment in children and adolescents is still limited because there are few randomized clinical trials (CTs), hampering appropriate management. The objective was to perform a narrative review of the most relevant aspects of clinical trials...

Full description

Saved in:
Bibliographic Details
Main Authors: Redón i Mas, Josep (Author) , Seeman, Tomas (Author) , Pall, Dénes (Author) , Suurorg, Lagle (Author) , Kamperis, Konstantinos (Author) , Erdine, Serap (Author) , Wühl, Elke (Author) , Mancia, Giuseppe (Author)
Format: Article (Journal)
Language:English
Published: 21 November 2022
In: Frontiers in Cardiovascular Medicine
Year: 2022, Volume: 9, Pages: 1-12
ISSN:2297-055X
DOI:10.3389/fcvm.2022.1042190
Online Access:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3389/fcvm.2022.1042190
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fcvm.2022.1042190
Get full text
Author Notes:Josep Redon, Tomas Seeman, Dénes Pall, Lagle Suurorg, Konstantinos Kamperis, Serap Erdine, Elke Wühl and Giuseppe Mancia
Description
Summary:To date, our knowledge on antihypertensive pharmacological treatment in children and adolescents is still limited because there are few randomized clinical trials (CTs), hampering appropriate management. The objective was to perform a narrative review of the most relevant aspects of clinical trials carried out in primary and secondary hypertension.
Item Description:Gesehen am 09.11.2023
Physical Description:Online Resource
ISSN:2297-055X
DOI:10.3389/fcvm.2022.1042190